Discovering novel quercetin-3-O-amino acid-esters as a new class of Src tyrosine kinase inhibitors

被引:29
|
作者
Huang, He [2 ]
Jia, Qi [1 ]
Ma, Jingui [2 ]
Qin, Guangrong [2 ]
Chen, Yingyi [1 ]
Xi, Yonghua [1 ]
Lin, Liping [2 ]
Zhu, Weiliang [2 ]
Ding, Jian [2 ]
Jiang, Hualiang [2 ]
Liu, Hong [2 ]
机构
[1] Shanghai Univ Tradit Chinese Med, Sch Chinese Med, Shanghai 201203, Peoples R China
[2] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China
基金
中国国家自然科学基金;
关键词
Quercetin; Amino acid; Src; EGFR; Inhibitor; QUERCETIN; GROWTH;
D O I
10.1016/j.ejmech.2008.09.051
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Quercetin-3-O-amino acid-esters, a new type of quercetin derivatives, were successfully prepared for the first time. Different from quercetin, the novel compounds show higher selectivity as inhibitors against Src tyrosine kinase (IC50 values ranging from 3.2 mu M to 9.9 mu M) than against EGFR tyrosine kinase. Molecular docking reveals that both hydrophobic and hydrogen bonding interactions are important to the selectivity. Therefore, this study provides a new promising scaffold for further development of new anticancer drugs targeting Src tyrosine kinase. (C) 2008 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:1982 / 1988
页数:7
相关论文
共 35 条
  • [21] Facile preparation of new 4-phenylamino-3-quinolinecarbonitrile Src kinase inhibitors via 7-fluoro intermediates: Identification of potent 7-amino analogs
    Boschelli, Diane H.
    Wu, Biqi
    Ye, Fei
    Durudic, Haris
    Golas, Jennifer M.
    Lucas, Judy
    Boschelli, Frank
    BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (01) : 405 - 412
  • [22] 3-Amino-7-phthalazinylbenzoisoxazoles as a Novel Class of Potent, Selective, and Orally Available Inhibitors of p38α Mitogen-Activated Protein Kinase
    Pettus, Liping H.
    Xu, Shirnin
    Cao, Guo-Qiang
    Chakrabarti, Partha P.
    Rzasa, Robert M.
    Sham, Kelvin
    Wurz, Ryan P.
    Zhang, Dawei
    Middleton, Scott
    Henkle, Bradley
    Plant, Matthew H.
    Saris, Christiaan J. M.
    Sherman, Lisa
    Wong, Lu Min
    Powers, David A.
    Tudor, Yanyan
    Yu, Violeta
    Lee, Matthew R.
    Syed, Rashid
    Hsieh, Faye
    Tasker, Andrew S.
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (20) : 6280 - 6292
  • [23] [4-(6,7-Disubstituted quinazolin-4-ylamino)phenyl] carbamic acid esters: a novel series of dual EGFR/VEGFR-2 tyrosine kinase inhibitors
    Garofalo, Antonio
    Goossens, Laurence
    Lemoine, Amelie
    Ravez, Severine
    Six, Perdue
    Howsam, Michael
    Farce, Amaury
    Depreux, Patrick
    MEDCHEMCOMM, 2011, 2 (01) : 65 - 72
  • [24] A shorter route for the syntheses of substituted 4-(INDOLE-3-YL)quinazolines, a new class of EGFR-tyrosine kinase inhibitors and their remarkable pharmacological results
    Lueth, A.
    Woege, S.
    Loewe, W.
    ONKOLOGIE, 2008, 31 : 135 - 135
  • [25] Definition of the binding mode of a new class of phosphoinositide 3-kinase α-selective inhibitors using in vitro mutagenesis of non-conserved amino acids and kinetic analysis
    Zheng, Zhaohua
    Amran, Syazwani I.
    Zhu, Jiuxiang
    Schmidt-Kittler, Oleg
    Kinzler, Kenneth W.
    Vogelstein, Bert
    Shepherd, Peter R.
    Thompson, Philip E.
    Jennings, Ian G.
    BIOCHEMICAL JOURNAL, 2012, 444 : 529 - 535
  • [26] CATECHOL-O-METHYLTRANSFERASE .2. A NEW CLASS OF INHIBITORS OF CATECHOL-O-METHYLTRASFERASE - 3,5-DIHYDROXY-4-METHOXYBENZOIC ACID AND RELATED COMPOUNDS
    NIKODEJEVIC, B
    SENOH, S
    DALY, JW
    CREVELING, CR
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1970, 174 (01): : 83 - +
  • [27] Design, synthesis and structure-activity relationship of diaryl-ureas with novel isoxazol[3,4-b]pyridine-3-amino-structure as multi-target inhibitors against receptor tyrosine kinase
    Shi, Zhi-Hao
    Liu, Feng-Tao
    Tian, Hao-Zhong
    Zhang, Yan-Min
    Li, Nian-Guang
    Lu, Tao
    BIOORGANIC & MEDICINAL CHEMISTRY, 2018, 26 (16) : 4735 - 4744
  • [28] In silico and in vitro evaluation of novel carbothioamide-based and heterocyclic derivatives of 4-(tert-butyl)-3-methoxybenzoic acid as EGFR tyrosine kinase allosteric site inhibitors
    Al-Rubaye, Imad M.
    Mahmood, Ammar A. Razzak
    Tahtamouni, Lubna H.
    AlSakhen, Mai F.
    Kanaan, Sana I.
    Saleh, Khaled M.
    Yasin, Salem R.
    RESULTS IN CHEMISTRY, 2024, 7
  • [29] Utilization of 3′-carboxy-containing tyrosine derivatives as a new class of phosphotyrosyl mimetics in the preparation of novel non-phosphorylated cyclic peptide inhibitors of the Grb2-SH2 domain
    Song, YL
    Tan, JZ
    Luo, XM
    Long, YQ
    ORGANIC & BIOMOLECULAR CHEMISTRY, 2006, 4 (04) : 659 - 666
  • [30] Novel chiral and organosoluble nanostructure poly(esterimide)s containing N,N′-(3,3′,4,4′-benzophenonetetracarboxylic)-3,3′,4,4′-diimido-bis-(L-tyrosine methyl ester) as a new amino acid based diol: production, morphology, and thermal properties
    Mallakpour, Shadpour
    Zeraatpisheh, Fatemeh
    DESIGNED MONOMERS AND POLYMERS, 2013, 16 (05) : 488 - 497